Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 1 May 2009, doi:10.1136/bmj.b1722
Cite this as: BMJ 2009;338:b1722
Geoff Watts, freelance journalist
1 London
geoff@scileg.freeserve.co.uk
Unlike drugs, surgical techniques are often not evaluated in randomised trials. Geoff Watts investigates why
| The first 150 words of the full text of this article appear below. |
Of the 12 million or so NHS hospital admissions that take place during any one year, at least 30% involve surgery. Yet in 2006-7 only 1.3% of government spending on medical research was devoted to surgery. Of course, the notion that research spending should correlate precisely with disease prevalence, medical workload, or any other measure of health burden is naive. But 30% against 1.3% is quite a difference. In the face of a gap this wide, the comment from Norman Williams, president of the Society of Academic and Research Surgery, that: "Theres a mismatch," seems positively understated.
Nor is he alone in his worries about the output of surgical research. Commentators have been raising the issue for years.1 Parliamentary committees have discussed it.2 And in the latest university research assessment exercise, the chairs of both panels responsible for appraising most of the work in the field commented on its poor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses